For citations:
Sanarova E.V., Borisova L.M., Kiseleva M.P., Nikolaeva L.L., Gusev D.V., Osipov V.N., Orlova O.L., Golubeva I.S., Lantsova A.V. Primary evaluation of a new 3-hydroxyquinazoline derivative initial – a potential inducer of ferroptosis antitumour activity. Russian Journal of Biotherapy. 2025;24(4):56-63. (In Russ.) https://doi.org/10.17650/1726-9784-2025-24-4-56-63
Email this article 